Performance of Comprehensive Risk Adjustment for the Prediction of In-Hospital Events Using Administrative Healthcare Data: The Queralt Indices

References

• Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol. 2000;29:891–898. doi:10.1093/ije/29.5.89111034974
   PubMed Web of Science ®Google Scholar
• Austin SR, Wong YN, Uzzo RG, Beck JR, Egleston BL. Why summary comorbidity measures such as the charlson comorbidity index and elixhauser score work. Med Care. 2015;53:e65–e72. doi:10.1097/MLR.0b013e318297429c23703645
   PubMed Web of Science ®Google Scholar
• Susser M, Susser E. Choosing a future for epidemiology: I. Eras and paradigms. Am J Public Health. 1996;86:668–673. doi:10.2105/AJPH.86.5.6688629717
   PubMed Web of Science ®Google Scholar
• Farré N, Vela E, Clèries M, et al. Real world heart failure epidemiology and outcome: a population-based analysis of 88,195 patients. PLoS One. 2017;12:e0172745. doi:10.1371/journal.pone.017274528235067
   PubMed Web of Science ®Google Scholar
• De Jong L, van Rijckevorsel VAJIM, Raats JW, Klem TMAL, Kuijper TM, Roukema GR. Delirium after hip hemiarthroplasty for proximal femoral fractures in elderly patients: risk factors and clinical outcomes. Clin Interv Aging. 2019;14:427–435. doi:10.2147/CIA.S18976030880924
   PubMed Web of Science ®Google Scholar
• Giuliano KK, Baker D, Quinn B. The epidemiology of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control. 2018;46:322–327. doi:10.1016/j.ajic.2017.09.00529050905
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383. doi:10.1016/0021-9681(87)90171-83558716
   PubMedGoogle Scholar
• Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27. doi:10.1097/00005650-199801000-000049431328
   PubMed Web of Science ®Google Scholar
• Stavem K, Hoel H, Skjaker SA, Haagensen R. Charlson comorbidity index derived from chart review or administrative data: agreement and prediction of mortality in intensive care patients. Clin Epidemiol. 2017;9:311–320. doi:10.2147/CLEP.S13362428652813
   PubMed Web of Science ®Google Scholar
• de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003;56:221–229. doi:10.1016/S0895-4356(02)00585-112725876
   PubMed Web of Science ®Google Scholar
• Ording AG, Sørensen HT. Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs. Clin Epidemiol. 2013;5:199–203. doi:10.2147/CLEP.S4530523861599
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. National Center for Health Statistics. International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Available from: https://www.cdc.gov/nchs/icd/icd10cm.htm. Accessed 6 6, 2019.
   Google Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–682. doi:10.1093/aje/kwq43321330339
   PubMed Web of Science ®Google Scholar
• van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47:626–633. doi:10.1097/MLR.0b013e31819432e519433995
   PubMedGoogle Scholar
• Averill RF, Goldfield N, Hughes JS, et al. All Patient Refined Diagnosis Related Groups (APR - DRGs): methodology overview. Available from: https://www.hcup-us.ahrq.gov/db/nation/nis/grp031_aprdrg_meth_ovrview.pdf. Accessed 66, 2020.
   Google Scholar
• Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21:128–138. doi:10.1097/EDE.0b013e3181c30fb220010215
   PubMed Web of Science ®Google Scholar
• Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716–723. doi:10.1109/TAC.1974.1100705
   Web of Science ®Google Scholar
• Schwarz C. Estimating the dimension of a model. Ann Stat. 1978;6:461–464. doi:10.1214/aos/1176344136
   Web of Science ®Google Scholar
• Brier G. Verification of forecasts expressed in terms of probability. Mon Weather Rev. 1950;78:1–3. doi:10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2
   Google Scholar
• DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–845. doi:10.2307/25315953203132
   PubMed Web of Science ®Google Scholar
• Clinical Classifications Software (CCS) for the ICD-10-CM/PCS. Available from: https://www.hcup-us.ahrq.gov/toolssoftware/ccs10/ccs_dx_icd10cm_2018_1.zip. Accessed 66, 2019.
   Google Scholar
• R Core Team. A Language and Environment for Statistical Computing. Vienna, Austria; 2014 Available from: https://www.r-project.org/. Accessed 66, 2019.
   Google Scholar
• CRAN - Package comorbidity - The R Project for Statistical Computing. Available from: https://cran.r-project.org/web/packages/comorbidity/index.html. Accessed 606, 2019.
   Google Scholar
• Lieffers JR, Baracos VE, Winget M, Fassbender K. A comparison of charlson and elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer. 2011;117:1957–1965. doi:10.1002/cncr.2565321509773
   PubMed Web of Science ®Google Scholar
• Gutacker N, Bloor K, Cookson R. Comparing the performance of the Charlson/Deyo and Elixhauser comorbidity measures across five European countries and three conditions. Eur J Public Health. 2015;25:15–20. doi:10.1093/eurpub/cku221
   Web of Science ®Google Scholar
• Sharabiani MTA, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50:1109–1118. doi:10.1097/MLR.0b013e31825f64d022929993
   PubMed Web of Science ®Google Scholar
• Moltó A, Dougados M. Comorbidity indices. Clin Exp Rheumatol. 2014;32:S-131–4.
   Web of Science ®Google Scholar
• Ahmad T, Pencina MJ, Schulte PJ, et al. Clinical implications of chronic heart failure phenotypes defined by cluster analysis. J Am Coll Cardiol. 2014;64:1765–1774. doi:10.1016/j.jacc.2014.07.97925443696
   PubMed Web of Science ®Google Scholar
• Suissa S, Garbe E. Primer: administrative health databases in observational studies of drug effects–advantages and disadvantages. Sami suissa Primer Nat Clin Pract Rheumatol. 2007;3:725–732. doi:10.1038/ncprheum0652
   PubMedGoogle Scholar
• Scott IA. Hope, hype and harms of big data. Intern Med J. 2019;49:126–129. doi:10.1111/imj.2019.49.issue-130680901
   PubMed Web of Science ®Google Scholar
• Ramos R, Comas-Cufí M, Martí-Lluch R, et al. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study. BMJ. 2018;362:k3359. doi:10.1136/bmj.k335930185425
   PubMed Web of Science ®Google Scholar
• Ramos R, Balló E, Marrugat J, et al. Validity for use in research on vascular diseases of the SIDIAP (Information System for the Development of Research in Primary Care): the EMMA study. Rev Esp Cardiol (Engl Ed). 2012;65:29–37. doi:10.1016/j.recesp.2011.07.017
   PubMed Web of Science ®Google Scholar
• Institut Catala de Salut. Projecte de Queralt. Available from: http://ics.gencat.cat/ca/assistencia/coneixement-assistencial/Projecte-de-Queralt/. Accessed 210, 2020.
   Google Scholar